Claims Management Support
Support for charge entry, coding review, claim scrubbing, submission, and rejection clearing across evaluation and management, infusion, and drug claims.
GrowInfectiousDisease helps infectious disease physicians, group leaders, and practice administrators understand and strengthen medical billing operations in New York. Explore practical support for claims management, denials, authorizations, infusion and drug billing, payment reconciliation, credentialing, and revenue-cycle improvement. The resource hub explains complex financial mechanics clearly while helping practices evaluate their own workflows, numbers, and sustainability.

Specialized billing and revenue-cycle support for infectious disease practices managing cognitive care, infusion, OPAT, and drug claims.
Support for charge entry, coding review, claim scrubbing, submission, and rejection clearing across evaluation and management, infusion, and drug claims.
Root-cause denial analysis and payer-specific appeals addressing authorization gaps, drug and administration coding, benefit confusion, and incomplete consult documentation.
Eligibility and benefit verification plus prior authorization support for infusions, OPAT courses, and specialty drugs, including medical and pharmacy benefit review.
Reconciliation of expected and received reimbursement for drugs, administration, and evaluation and management claims, with attention to short-pays and coding mismatches.
CAQH, commercial and government payer enrollment, and re-credentialing support for physicians, APPs, infusion services, and OPAT programs.
A practical review of workflows from referral through final payment, covering documentation, coding, authorization, drug acquisition, collections, and contracts.
Infectious disease billing combines cognitive services with infusion, OPAT, and drug reimbursement, creating financial issues that general billing resources may overlook. GrowInfectiousDisease provides plain-English guidance and practical tools for evaluating documentation, authorization, charge capture, denials, underpayments, and aging claims. New York practices can use their own information to examine revenue-cycle gaps without relying on unsupported rates, margins, or generalized assumptions.

Get focused, transparent guidance for the financial mechanics of independent infectious disease practice.
Guidance is tailored to infectious disease economics, including OPAT, infusion, buy-and-bill, and revenue-cycle management.
Verified information is distinguished from unknown or practice-specific figures, helping New York practices avoid unsupported assumptions.
Browser-based tools and explainers provide actionable guidance without requiring an email submission or gated access.
Tools let practices apply their own numbers, with entered information running in the browser without transmission or storage.
A focused resource hub for independent infectious disease practice economics.
GrowInfectiousDisease was created in response to the economic complexity of infectious disease practices and the limited business and financial training often provided during fellowship. The resource hub helps infectious disease physicians, group leaders, and practice administrators understand operational decisions affecting practice sustainability. Its guidance covers OPAT, infusion services, reimbursement, staffing, contracts, and revenue-cycle management. For practices serving patients in New York and elsewhere in the United States, the goal is practical clarity rather than unsupported certainty. GrowInfectiousDisease explains how money moves through the practice, offers free ungated tools and browser-based calculators, and makes clear which figures require practice-specific information. It does not publish invented rates, drug acquisition costs, payment rates, or margin assumptions.
Popular medical billing software varies by practice size, specialty, workflow, and existing electronic health record. A suitable platform should support claims submission, eligibility, authorization tracking, denial work queues, payment posting, reporting, and integration with clinical systems. Infectious disease practices should also assess support for infusion, OPAT, drug, and evaluation and management billing rather than choosing software based only on general popularity.
Use focused guidance to examine your infectious disease practice’s revenue cycle.
Explore practical resources and apply your own practice information to understand revenue-cycle opportunities.
To help us assist you faster, please include the reason for your message so the relevant team can reach out as soon as possible.
To help us assist you faster, please include the reason for your message so the relevant team can reach out as soon as possible.